Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Depreciation and Depletion (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Depreciation and Depletion for 4 consecutive years, with $6841.0 as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion changed 0.01% to $6841.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27361.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $27361.0 for FY2025, 0.0% changed from the prior year.
  • Depreciation and Depletion hit $6841.0 in Q4 2025 for Coya Therapeutics, roughly flat from $6840.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $12455.0 in Q3 2022 to a low of $4033.0 in Q1 2022.
  • Historically, Depreciation and Depletion has averaged $6840.2 across 4 years, with a median of $6840.0 in 2022.
  • Biggest YoY gain for Depreciation and Depletion was 69.6% in 2023; the steepest drop was 45.07% in 2023.
  • Year by year, Depreciation and Depletion stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then grew by 0.01% to $6841.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for COYA at $6841.0 in Q4 2025, $6840.0 in Q3 2025, and $6840.0 in Q2 2025.